Cheol Kyu Han

Title: Cheol Kyu Han: Innovator in Angiogenesis Inhibition

Introduction

Cheol Kyu Han is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit angiogenesis. His work is crucial for advancing treatments for various diseases where angiogenesis plays a key role.

Latest Patents

Cheol Kyu Han holds a patent for "Fumagillol derivatives and processes for preparing the same." This patent describes compounds that are useful as angiogenesis inhibiting agents. The compounds are represented by a specific formula and include a pharmaceutical composition aimed at inhibiting angiogenesis in mammals. This innovation has the potential to impact therapeutic strategies significantly.

Career Highlights

Throughout his career, Cheol Kyu Han has worked with prominent companies in the pharmaceutical industry. Notable among these are Chong Kun Dang Corporation and Bamichem Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Cheol Kyu Han has collaborated with several professionals in his field, including Chung Il Hong and Jung Woo Kim. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Cheol Kyu Han is a distinguished inventor whose work in angiogenesis inhibition is paving the way for new therapeutic options. His contributions to the pharmaceutical industry are noteworthy and continue to influence the field positively.